Most articles about implant removal are written as though the decision has to be justified. They open by listing the complications that make removal medically necessary, as if wanting implants out were a position requiring a note from a doctor.
A large share of the patients who ask about explant have none of those complications. The implants are intact. Nothing has hardened. Nothing has leaked. What has changed is the patient. She is twenty years older than the woman who chose them, or she no longer wants the maintenance, or she has become convinced they are making her unwell, or she simply looked in the mirror and decided she was done. That is a sufficient reason, and a consultation that treats it as one gets further than a consultation that argues.
What follows covers removal without replacement specifically. The mechanical problems that bring patients in for exchange rather than removal, meaning capsular contracture and implant rupture, are dealt with on the practice page covering breast implant revision and are not repeated here. Dr. John Ayala, a board certified plastic surgeon in San Antonio, treats explant as its own operation with its own decisions, because it is.
The Three Questions That Make Up an Explant Plan
Every explant consultation resolves into three questions, and they are independent of one another. Patients often arrive believing they are one question with one answer.
The first is what comes out. The implant certainly. The capsule, meaning the layer of scar tissue the body built around it, is a separate decision with its own reasoning.
The second is what happens to the skin and tissue left behind. The envelope has been stretched for years and will not simply contract back to where it started.
The third is whether anything replaces the volume, and if so, what.
A surgeon who answers all three at once, in a single sentence, has skipped the part of the conversation that determines whether the patient is happy at six months.
Breast Implant Illness
A substantial number of explant requests now come from patients who attribute systemic symptoms to their implants. Fatigue, joint and muscle pain, cognitive fog, hair loss, rashes, dry eyes, and a general sense of being unwell are the ones most commonly described.
The honest state of the evidence is uncomfortable for everyone involved, because it does not support either of the two confident positions people take.
Breast implant illness is not a formal diagnosis. There is no blood test, no imaging finding, and no agreed set of criteria that establishes it. The symptom cluster overlaps heavily with conditions that are common in women of the same age range, including thyroid disease, autoimmune disease, anemia, vitamin D deficiency, sleep disorders, and perimenopause. Large population studies have not demonstrated that implants cause a defined systemic illness.
At the same time, patient reported outcome studies have documented meaningful symptom improvement in a significant proportion of patients following explant. Those studies generally lack control groups and cannot separate a biological effect from the expectation of improvement, which is a real limitation and not a dismissal.
Both of those statements are true simultaneously, and a surgeon who presents only one of them is not being straight.
What That Means for the Consultation
Two things follow in practice.
A workup for other causes comes first, because several of the alternatives are treatable and a few are serious. A patient who explants without having her thyroid checked and whose fatigue was thyroid in origin has had an operation and still has the symptom. That outcome is avoidable.
And a patient who wants her implants removed is entitled to that operation whether or not a cause is found. She does not need a validated diagnosis to make a decision about her own body. What she needs is accurate information about what explant will and will not change, which is that symptom relief is not guaranteed, that when it happens it is not uniform across symptoms, and that the cosmetic result follows the same rules as any other explant.
A consultation that offers that is more useful than one that promises a cure, and far more useful than one that refuses to engage.
A Note on Testing
Patients sometimes ask for the capsule or the implant to be sent for laboratory analysis in the hope of confirming a diagnosis. Capsule tissue is routinely sent to pathology when there is a clinical reason, such as an unexplained fluid collection or a suspicious mass. There is no test that confirms breast implant illness from a specimen, and no surgeon can produce one, because the condition has no defined pathological finding. Being told this in advance prevents a disappointing phone call later.
BIA-ALCL, Which Is a Different Thing Entirely
Breast implant associated anaplastic large cell lymphoma is frequently confused with breast implant illness, and the two have almost nothing in common beyond both involving implants.
It is a rare cancer of the immune system that arises in the capsule around an implant. It is not breast cancer. Identified cases have been overwhelmingly associated with textured surface implants rather than smooth ones, and certain textured devices were withdrawn from the market because of it.
It typically presents as a large fluid collection around an implant appearing years after an uneventful augmentation, sometimes as a mass or persistent one sided swelling. A breast that suddenly enlarges long after surgery warrants prompt imaging rather than reassurance.
Where it is confirmed or suspected, complete removal of the implant together with the entire capsule is the treatment, and the prognosis when caught at that stage is generally favorable. Patients with smooth implants are not advised to explant preventively on this basis, and asymptomatic patients with textured devices are usually advised on monitoring rather than automatic removal. Anyone who does not know which surface type they have can find it recorded in the operative note or on the implant identification card issued at the original surgery.
En Bloc: What the Term Actually Means
Few phrases in plastic surgery have drifted further from their original meaning, and patients are frequently told they must insist on it without being told what it is.
En bloc is a surgical oncology term. It describes removing a mass together with surrounding tissue as a single sealed unit, without cutting into the specimen, so that no cells escape into the surgical field. It entered the implant conversation and now functions in patient forums as shorthand for take everything out and do it properly.
The accurate vocabulary is three terms. Total capsulectomy means the whole capsule is removed. Total intact capsulectomy, which is what nearly everyone means when they say en bloc, means the capsule comes out in one unopened piece with the implant still sealed inside it. Partial capsulectomy means part of the capsule is removed and part is left in place.
Why an Unconditional Promise Is a Warning Sign
Intact removal depends on anatomy that nobody can assess fully before the operation starts. The capsule on the deep surface of the pocket sits against the rib cage and the muscle covering it, and in a thin patient it can be a fraction of a millimeter thick in places, fused to the tissue beneath it.
Pursuing a perfectly intact specimen in that situation can mean stripping periosteum from rib, entering the chest cavity, or causing a pneumothorax, which is a collapsed lung requiring a chest tube. None of those risks are justified by the specimen arriving in the pathology tray unopened.
A surgeon who guarantees intact removal in all circumstances is promising something that is not entirely within their control. The useful version of that conversation sounds different. It sets total capsulectomy as the goal wherever the tissue planes permit it, and states in advance what will be done if a specific area proves adherent. Patients are entitled to ask that question directly and to expect a real answer rather than a slogan.
Does the Capsule Have to Come Out at All?
This is the question patients research least and surgeons weigh most.
A capsule that is thin, soft, and uninflamed is not inherently harmful, and a small, pliable capsule left in place often resorbs over time once the implant that was holding it open is gone. Removing it adds operating time, dissection, bleeding, and in thin patients a measure of risk to the chest wall.
There are clear reasons to remove it. Thickened or calcified capsules do not resorb and can be felt as firm plaques under the skin. Capsules containing silicone from a ruptured implant are removed with the silicone. Where lymphoma is suspected, complete removal is the treatment. And where a patient has made an informed decision that she wants the capsule out as part of addressing systemic symptoms, that preference is a legitimate input even though the evidence does not establish that the capsule is causing them.
What is not useful is an absolute rule in either direction. The reasonable approach examines the capsule's actual condition, the patient's reason for explanting, and the anatomy in front of the surgeon, and arrives at a plan for that patient.
What the Chest Actually Looks Like Afterward
This is the part of explant that produces the most disappointment, almost always because nobody set the expectation properly.
The breast after removal is not the breast from before the augmentation. It is the tissue that exists now, which has been stretched for years, has aged since the implant was placed, has usually been through weight changes, and in many cases has thinned where the implant pressed against it. The skin envelope was sized for a volume that is no longer there.
Several factors predict how much change to expect. A patient who had meaningful breast tissue of her own and modest implants sees the least dramatic difference. A patient who was small framed with little native tissue and received large implants sees the most. Skin quality matters, so younger skin with good elasticity retracts better than skin that has been stretched for two decades. Pregnancy and breastfeeding since the augmentation reduce how much the tissue will recoil. Placement above the muscle versus beneath it changes the contour of what remains.
The Timeline, Which Is Longer Than Patients Expect
The first few weeks after explant are not representative of anything. Swelling fills part of the space the implant occupied, the pocket has not collapsed, and the breast looks flatter and more deflated than it eventually will.
Tissue retracts over months rather than weeks. Shape at six weeks is not final shape, and shape at three months is still settling. A fair assessment sits closer to six months, and patients who make decisions about further surgery before then frequently decide differently once the tissue has finished moving.
Some degree of asymmetry is normal afterward, because the two sides rarely retract identically, and it often evens out over the same period. Looking through cases in the practice before and after gallery is more informative on this point than any written description, because the difference between an explant alone and an explant with additional work is immediately visible.
When a Lift Belongs in the Same Operation
For a patient with significant skin laxity, combining removal with a breast lift addresses what explant alone cannot. The lift raises the nipple to a position appropriate for the smaller breast, removes excess skin, and reshapes what remains into a tighter cone.
The genuine decision is not whether, but when.
Doing both at once means one anesthetic, one recovery period, and one set of time away from work. For many patients it is the right choice and the predictable one.
Staging the lift for a later date has specific advantages. The surgeon plans the lift against tissue that has finished retracting rather than estimating where it will end up. That matters most in patients who had very large implants, who have thin tissue, or who smoke, because combining an explant with a lift involves operating on skin whose blood supply has just been disrupted by the removal. In those cases splitting the operations trades convenience for safety and precision.
A patient who is undecided loses nothing by explanting first and reassessing at six months. The lift remains available. The reverse, undoing a lift planned against tissue that then moved, is not a straightforward proposition.
Replacing Volume Without Implants
Some patients want to be rid of implants without accepting the volume loss that comes with it. Transferring the patient's own fat is the option that exists, and it works within limits that should be stated before anyone gets excited about it.
Fat is harvested by liposuction from the abdomen, flanks, or thighs, processed, and injected into the breast in many small deposits rather than as a single mass. Placing it in small amounts matters, because transferred fat survives only where it is close enough to existing blood supply to be nourished until it establishes its own.
The limits are these. A session adds a modest amount of volume, not implant scale volume. A proportion of the transferred fat does not survive, which is expected and is why surgeons deliberately overfill. More than one session is often needed to reach a given result. And the technique requires donor fat, so a very lean patient may not have enough to work with, which is the constraint that rules it out most often.
What fat grafting does particularly well, and what is underappreciated, is improve the quality of thin tissue over the chest wall rather than simply adding size. The same principles govern facial fat transfer, where small volume placement and partial take behave identically.
For patients whose main concern is a hollow or thin upper pole after explant rather than overall size, grafting is frequently a better answer than it appears on paper.
Skin Retraction: What Helps and What Does Not
Once a patient understands that the skin envelope has to shrink around less volume, the obvious next question is whether anything can be done to help it along. The answer is partly yes and mostly no, and the honest version saves money.
What genuinely influences retraction is largely decided before the operation. Skin elasticity is the dominant factor, and it is a property of age, genetics, sun exposure history, and how long and how far the skin has been stretched. A thirty two year old with five year old moderate implants retracts well. A fifty eight year old whose skin has accommodated large implants for twenty years retracts less, regardless of what is done afterward.
Weight stability matters, because losing weight after explant thins the remaining tissue further and works against the result. Being at a settled weight before surgery rather than mid way through a change gives the most predictable outcome. Smoking impairs healing and blood supply to the skin, and it matters more here than patients expect, particularly when a lift is involved.
Compression is used after surgery, but it is worth being clear about what it does. A support garment manages swelling and keeps the tissue settled against the chest wall while the pocket closes. It is comfort and swelling control. It does not tighten skin that would not otherwise have tightened.
What does not work is the long list patients are sold. Creams do not retract a stretched skin envelope. Massage does not. Exercise builds the pectoralis muscle beneath the breast, which can improve the appearance of the chest overall, but it does not act on breast skin, because the breast is not muscle.
Energy based skin tightening devices occupy an awkward middle ground. They can produce modest improvement in skin quality in some areas of the body, and they are legitimately useful for some patients, but they are not a substitute for a lift where there is meaningful excess skin, and expecting them to be produces disappointment and an invoice. The specific devices a practice has available and whether any of them is appropriate after explant is a question for consultation rather than something to assume from a website.
The useful framing is this. Retraction will do what it does over six months. If what remains after that is acceptable, nothing more is needed. If it is not, the answer is a lift, and no intervening treatment changes which of those two outcomes applies.
Changing Your Mind Later
A small number of patients explant and later decide they preferred having implants. It is uncommon, it is not a failure, and it is worth knowing in advance that the door is not permanently closed.
Re augmentation after explant is possible. It is also not the same operation as the original, and that is the part worth understanding before explanting rather than after. The pocket has closed and scarred. The tissue has been through two operations. If a lift was performed at explant, the skin envelope has been reduced and reshaped, so a subsequent implant has to be sized to what exists now rather than to what existed originally. Planning a second breast augmentation in that setting involves more variables than the first one did.
The practical implication is about sequencing rather than discouragement. A patient who is genuinely unsure whether she wants to be without implants is better served by explanting without a lift first and deciding at six months, because that preserves the most options. A patient who is certain can proceed with whatever combination suits her anatomy.
What does not help is being pressured either way. A surgeon who treats explant as a decision to be talked out of is unhelpful, and so is one who treats the possibility of changing one's mind as a weakness. Both are ordinary human outcomes and both are surgically manageable.
Preparing for the Operation
Records
Explant planning improves considerably when the original paperwork exists. The operative report records implant size, fill, surface type, and the plane the implant was placed in. The implant identification cards carry manufacturer, style, and serial number, which is also how a patient establishes whether her device was one of the recalled textured models.
If those documents are gone, the original surgeon or the facility where the operation was performed may still hold them. Where nothing exists, which is common with surgery performed decades ago or in another country, the plan is built from examination and imaging instead. That is entirely workable. It is simply less precise, and it means more of the plan is confirmed in the operating room rather than before it.
Imaging
Ultrasound and MRI both assess implant integrity, with MRI more sensitive and ultrasound more accessible as a first look. Imaging also characterizes any fluid collection or mass, which is what distinguishes an ordinary explant from the lymphoma question described earlier.
Routine mammographic screening continues on the schedule appropriate to the patient's age and risk, both before and after explant, with the imaging center told implants are present so the correct views are taken.
What Changes Afterward
Bra size changes, and buying new ones before the tissue has settled is money spent twice. Scars continue to mature for a year or more and look worse at three months than they will at twelve. Imaging gets easier rather than harder once implants are gone, since the views no longer have to work around a device.
Patients traveling from Laredo, Del Rio, Corpus Christi, or the Rio Grande Valley should plan the follow up visits in advance, and the practice guidance for out of town patients sets out how those are normally arranged.
Choosing a Surgeon for Explant
The verifiable credentials matter here as they do anywhere. Certification by the American Board of Plastic Surgery rather than a board with a similar sounding name, hospital privileges to perform the procedure, an accredited operating facility, and anesthesia delivered by a qualified anesthesia provider. Those sit behind the credentials listed for Dr. Ayala and should be confirmed for anyone under consideration.
Beyond that, explant has a specific test that other operations do not.
A patient who says she wants her implants out and is met with a pitch for replacing them with something better has learned something important about that consultation. So has a patient who asks what happens if the capsule proves adherent and receives a guarantee rather than a plan. The surgeons worth trusting with this operation are specific about what they control, candid about what they do not, and willing to perform an operation that makes the patient smaller.
A consultation turns the general into the particular. Examination, records, and imaging convert the options described here into one recommended plan, and that conversation can be arranged through the practice contact page.
Frequently Asked Questions
What is the difference between en bloc and total capsulectomy?
Total capsulectomy means the entire capsule is removed. Total intact capsulectomy, which is what most patients mean by en bloc, means the capsule comes out in one unopened piece with the implant sealed inside it. Intact removal is not always anatomically achievable, because the capsule against the rib cage can be adherent and extremely thin, and pursuing an intact specimen there risks injury to the chest wall including a collapsed lung. A surgeon who guarantees it unconditionally is promising something outside their control. The reasonable plan sets total capsulectomy as the goal where the tissue planes allow it and states in advance how adherent areas will be handled.
Will the breasts look the way they did before the augmentation?
No. The breast after removal reflects the tissue present now, which has been stretched for years, has aged, has often been through weight changes or pregnancy, and in many cases has thinned where the implant pressed on it. Patients who had meaningful native tissue and modest implants see the least change. Those who were small framed with large implants see the most. Skin elasticity and the original placement plane also affect the result.
How long before the breasts settle into their final shape?
Longer than most patients expect. The first weeks are dominated by swelling and a pocket that has not yet collapsed, so the breast looks flatter than it eventually will. Tissue retracts over months. Shape at six weeks is not final, three months is still settling, and a fair assessment sits closer to six months. Some asymmetry during that period is normal and frequently evens out.
Does the capsule have to be removed?
Not in every case. A thin, soft, uninflamed capsule is not inherently harmful and often resorbs once the implant holding it open is gone. There are clear reasons to remove it, including a thickened or calcified capsule, silicone from a ruptured implant, suspected lymphoma, and an informed patient preference where systemic symptoms are the reason for explanting. Removal adds dissection and, in very thin patients, some risk to the chest wall, so the decision is made on the capsule's actual condition and the individual anatomy rather than on a blanket rule.
Can the capsule be tested to confirm breast implant illness?
No. Capsule tissue is routinely sent to pathology when there is a clinical reason such as an unexplained fluid collection or a suspicious mass. There is no laboratory test that confirms breast implant illness from a specimen, because the condition has no defined pathological finding and no agreed diagnostic criteria. Knowing this before surgery avoids a disappointing result later.
Should the lift be done at the same time or later?
Both are reasonable and the choice is individual. Combining them means one anesthetic and one recovery. Staging allows the lift to be planned against tissue that has finished retracting rather than against an estimate, which matters most for patients who had very large implants, who have thin tissue, or who smoke, since a combined operation involves lifting skin whose blood supply was just disrupted. A patient who is undecided loses nothing by explanting first and reassessing at six months.
How much volume can fat grafting replace after explant?
A modest amount per session rather than implant scale volume. A proportion of transferred fat does not survive, which is expected and why surgeons overfill deliberately, and more than one session is often needed. It also requires donor fat, so a very lean patient may not have enough available. Where it performs best is improving the quality and thickness of thin tissue over the chest wall rather than adding size, which suits patients whose main concern is hollowness rather than volume.
Is BIA-ALCL the same as breast implant illness?
No, and the two have almost nothing in common. BIA-ALCL is a rare, defined cancer of the immune system arising in the capsule, associated overwhelmingly with textured rather than smooth implants, and usually presenting as a late fluid collection or one sided swelling. It has a diagnosis, a treatment, and a generally favorable prognosis when caught at that stage. Breast implant illness describes a cluster of systemic symptoms with no diagnostic test and no defined pathology.